Synthesis and use of an amphiphilic dendrimer for siRNA delivery into primary immune cells

被引:42
作者
Chen, Jiaxuan [1 ,2 ,3 ]
Ellert-Miklaszewska, Aleksandra [4 ]
Garofalo, Stefano [5 ]
Dey, Arindam K. [6 ]
Tang, Jingjie [1 ]
Jiang, Yifan [1 ]
Clement, Flora [6 ]
Marche, Patrice N. [6 ]
Liu, Xiaoxuan [2 ,3 ]
Kaminska, Bozena [4 ]
Santoni, Angela [7 ]
Limatola, Cristina [5 ,7 ]
Rossi, John J. [8 ]
Zhou, Jiehua [8 ]
Peng, Ling [1 ]
机构
[1] Aix Marseille Univ, Ctr Interdisciplinaire Nanosci Marseille, CNRS, UMR 7325,Equipe Labellisee Ligue Canc, Marseille, France
[2] China Pharmaceut Univ, Ctr Adv Pharmaceut & Biomat, Ctr Drug Discovery, State Key Lab Nat Med, Nanjing, Peoples R China
[3] China Pharmaceut Univ, Ctr Adv Pharmaceut & Biomat, Ctr Drug Discovery, Jiangsu Key Lab Drug Discovery Metab Dis, Nanjing, Peoples R China
[4] Polish Acad Sci, Nencki Inst Expt Biol, Neurobiol Ctr, Lab Mol Neurobiol, Warsaw, Poland
[5] Sapienza Univ Rome, Dept Physiol & Pharmacol, Rome, Italy
[6] Univ Grenoble Alpes, Inst Adv Biosci, CNRS 5309, INSERM,U1209, La Tronche, France
[7] IRCCS Neuromed, Pozzilli, Italy
[8] City Hope Med Ctr, Beckman Res Inst, Dept Mol & Cellular Biol, Monrovia, CA 91016 USA
关键词
JANUS KINASE INHIBITORS; SMALL INTERFERING RNA; IN-VITRO; MECHANISMS; STIMULATION; EFFICIENT; PROTEINS; DESIGN;
D O I
10.1038/s41596-020-00418-9
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Using siRNAs to genetically manipulate immune cells is important to both basic immunological studies and therapeutic applications. However, siRNA delivery is challenging because primary immune cells are often sensitive to the delivery materials and generate immune responses. We have recently developed an amphiphilic dendrimer that is able to deliver siRNA to a variety of cells, including primary immune cells. We provide here a protocol for the synthesis of this dendrimer, as well as siRNA delivery to immune cells such as primary T and B cells, natural killer cells, macrophages, and primary microglia. The dendrimer synthesis entails straightforward click coupling followed by an amidation reaction, and the siRNA delivery protocol requires simple mixing of the siRNA and dendrimer in buffer, with subsequent application to the primary immune cells to achieve effective and functional siRNA delivery. This dendrimer-mediated siRNA delivery largely outperforms the standard electroporation technique, opening a new avenue for functional and therapeutic studies of the immune system. The whole protocol encompasses the dendrimer synthesis, which takes 10 days; the primary immune cell preparation, which takes 3-10 d, depending on the tissue source and cell type; the dendrimer-mediated siRNA delivery; and subsequent functional assays, which take an additional 3-6 d. Delivery of siRNAs to immune cells is challenging because of these cells' sensitivity to standard transfection reagents. This protocol describes how to synthesize an amphiphilic dendrimer and apply it to transfect siRNAs in a variety of primary immune cells.
引用
收藏
页码:327 / 351
页数:25
相关论文
共 39 条
[1]   Rational design and in vitro and in vivo delivery of Dicer substrate siRNA [J].
Amarzguioui, Mohammed ;
Lundberg, Patric ;
Cantin, Edouard ;
Hagstrom, James ;
Behlke, Mark A. ;
Rossi, John J. .
NATURE PROTOCOLS, 2006, 1 (02) :508-517
[2]  
Armarego W.L. F., 1996, PURIFICATION LAB CHE, V4th
[3]   Mastering Dendrimer Self-Assembly for Efficient siRNA Delivery: From Conceptual Design to In Vivo Efficient Gene Silencing [J].
Chen, Chao ;
Posocco, Paola ;
Liu, Xiaoxuan ;
Cheng, Qiang ;
Laurini, Erik ;
Zhou, Jiehua ;
Liu, Cheng ;
Wang, Yang ;
Tang, Jingjie ;
Dal Col, Valentina ;
Yu, Tianzhu ;
Giorgio, Suzanne ;
Fermeglia, Maurizio ;
Qu, Fanqi ;
Liang, Zicai ;
Rossi, John J. ;
Liu, Minghua ;
Rocchi, Palma ;
Pricl, Sabrina ;
Peng, Ling .
SMALL, 2016, 12 (27) :3667-3676
[4]   Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles [J].
Davis, Mark E. ;
Zuckerman, Jonathan E. ;
Choi, Chung Hang J. ;
Seligson, David ;
Tolcher, Anthony ;
Alabi, Christopher A. ;
Yen, Yun ;
Heidel, Jeremy D. ;
Ribas, Antoni .
NATURE, 2010, 464 (7291) :1067-U140
[5]   The Future of Janus Kinase Inhibitors in Inflammatory Bowel Disease [J].
De Vries, L. C. S. ;
Wildenberg, M. E. ;
De Jonge, W. J. ;
D'Haens, G. R. .
JOURNAL OF CROHNS & COLITIS, 2017, 11 (07) :885-893
[6]   A Dual Targeting Dendrimer-Mediated siRNA Delivery System for Effective Gene Silencing in Cancer Therapy [J].
Dong, Yiwen ;
Yu, Tianzhu ;
Ding, Ling ;
Laurini, Erik ;
Huang, Yuanyu ;
Zhang, Mengjie ;
Weng, Yuhua ;
Lin, Shuting ;
Chen, Peng ;
Marson, Domenico ;
Jiang, Yifan ;
Giorgio, Suzanne ;
Pricl, Sabrina ;
Liu, Xiaoxuan ;
Rocchi, Palma ;
Peng, Ling .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2018, 140 (47) :16264-16274
[7]   Efficient and innocuous delivery of small interfering RNA to microglia using an amphiphilic dendrimer nanovector [J].
Ellert-Miklaszewska, Aleksandra ;
Ochocka, Natalia ;
Maleszewska, Marta ;
Ding, Ling ;
Laurini, Erik ;
Jiang, Yifan ;
Roura, Adria-Jaume ;
Giorgio, Suzanne ;
Gielniewski, Bartlomiej ;
Pricl, Sabrina ;
Peng, Ling ;
Kaminska, Bozena .
NANOMEDICINE, 2019, 14 (18) :2441-2458
[8]   THE HUMAN IMMUNODEFICIENCY VIRUS - INFECTIVITY AND MECHANISMS OF PATHOGENESIS [J].
FAUCI, AS .
SCIENCE, 1988, 239 (4840) :617-622
[9]   HIV-1: Fifteen proteins and an RNA [J].
Frankel, AD ;
Young, JAT .
ANNUAL REVIEW OF BIOCHEMISTRY, 1998, 67 :1-25
[10]   Advances in siRNA delivery to T-cells: potential clinical applications for inflammatory disease, cancer and infection [J].
Freeley, Michael ;
Long, Aideen .
BIOCHEMICAL JOURNAL, 2013, 455 :133-147